Overexpression of a dominant-negative Smad2 mutant, Smad2 (3A), in Huh-7 HCC cell line, leads to activation of Smad3/Smad4 signaling and transcriptional induction of TGF-β, PAI-1 and VEGF [74]. Here, SMAD2 is linked to hepatocellular carcinoma.